-
161
Pharmacological class effects of anticancer drugs: opportunities for decreasing healthcare spending
Published 2024-07-01“…In the field of general medicine, class effects, or therapeutic interchangeability, have been declared for several families of drugs including statins, calcium channel blockers and ACE inhibitors. …”
Get full text
Article -
162
Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis
Published 2025-12-01“…Certain drugs like aspirin, statins, GLP-1 RAs, and metformin may reduce HCC occurrence, but further research is needed to confirm these effects.…”
Get full text
Article -
163
Comprehensive review of myocardial injury after noncardiac surgery: prevention, intervention, and long-term management strategies
Published 2025-01-01“…We discuss the role of aspirin, statins, anticoagulation, and Dual Antiplatelet Therapy (DAPT) within the context of MINS, drawing on evidence from notable clinical trials as well as observational studies. …”
Get full text
Article -
164
Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy following mRNA SARS-CoV-2 Vaccination
Published 2023-01-01“…The diagnosis of probable post-vaccination IMNM was made due to the absence of other factors that may have led to the development of autoantibodies (medicines; e.g., statins, drugs) and the temporal relationship between exposure and event. …”
Get full text
Article -
165
Survey of medication history of patients with stroke after discharge from an acute hospital ward: a case series study
Published 2025-02-01“…Furthermore, discrepancies in medication discontinuation or reduction recommended by a stroke specialist, which may increase the risk of stroke recurrence, were identified in five patients (seven drugs: four antiplatelet drugs and three statins). Of 13 discrepancies, community pharmacists inquired about 3 cases with physicians, none were approved. …”
Get full text
Article -
166
Atorvastatin Improves Inflammatory Response in Atherosclerosis by Upregulating the Expression of GARP
Published 2015-01-01“…The antiatherosclerosis effects of statins partly depend on their multiple immune modulatory potencies. …”
Get full text
Article -
167
Vasospasm in Cerebral Inflammation
Published 2014-01-01“…Therapeutic trials in vasospasm related to inflammation in subarachnoid haemorrhage in humans showed a reduction of vasospasm through calcium antagonists, endothelin receptor antagonists, statins, and plasminogen activators. Combination of therapeutic modalities addressing calcium dependent and independent vasospasm, the underlying inflammation, and depletion of nitric oxide simultaneously merit further study in all conditions with cerebral inflammation in double blind randomised placebo controlled trials. …”
Get full text
Article -
168
The Chylomicron: Relationship to Atherosclerosis
Published 2012-01-01“…The ratio of dietary to synthesised cholesterol is variable but tightly regulated: hence intervention with diet at best reduces serum cholesterol by <20% andusually <10%. Statins are the mainstay of cholesterol reduction therapy, but they increase cholesterol absorption, an example of the relationship between synthesis and absorption. …”
Get full text
Article -
169
Stroke Prevention: Managing Modifiable Risk Factors
Published 2012-01-01“…The use of antiplatelets and statins has been shown to reduce the risk of recurrent stroke and other vascular events. …”
Get full text
Article -
170
Cerebral Cavernous Malformation: From Genetics to Pharmacotherapy
Published 2025-01-01“…Results Germline and somatic mutations mediate the onset and development of CCM through several molecular pathways. Medications such as statins, fasudil, rapamycin, and propranolol can alleviate CCM symptoms or hinder its progression by specifically modulating the corresponding targets. …”
Get full text
Article -
171
Overview of Community-Acquired Pneumonia and the Role of Inflammatory Mechanisms in the Immunopathogenesis of Severe Pneumococcal Disease
Published 2013-01-01“…This is focused on macrolides, corticosteroids, and statins with respect to their modes of anti-inflammatory action, current status, and limitations.…”
Get full text
Article -
172
The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination
Published 2012-01-01“…In spite of this, several groups reported exciting results with therapeutic regimens that combine PPARγ ligands with other compounds: chemotherapeutic agents, retinoid x receptor (RXR)α agonists, statins, or cell-to-cell signaling molecules in preclinical cancer models and human trials. …”
Get full text
Article -
173
Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue
Published 2018-01-01“…We revised the effects, and underlying mechanisms, of the current approved drugs for dyslipidemia and obesity (fibrates, statins, niacin, resins, ezetimibe, and orlistat; sibutramine; and diethylpropion, phentermine/topiramate, bupropion and naltrexone, and liraglutide) on adipose tissue. …”
Get full text
Article -
174
Telomere Biology: Key to unlocking the fountain of youth…A Systematic Review.
Published 2024-11-01“…As the role of telomere biology is well established in ageing,current research therefore aims to develop means to reduce telomere attrition,thereby reducing ageing & age related diseases.This review will focus on summarising the role of telomere biology in ageing & age related diseases while highlighting the recent advances in research aiming towards enhanced longevity & healthy ageing.This review will further emphasize on telomere targetted therapeutics such as telomerase activators & tankyrase inhibitors while also highlighting the role of antioxidative & antiinflammatory agents alongwith indirectly related approaches such as statins.…”
Get full text
Article -
175
Anti-Hyperlipidemic Effect of Zinc complex of Betulinic acid in High Fat Diet- Induced Hyperlipidemia
Published 2023-04-01“…Drugs of first choice, Statins, despite being well tolerable, are accompanied by many adverse effects. …”
Get full text
Article -
176
Current Controversies in the Prediction, Diagnosis, and Management of Cerebral Vasospasm: Where Do We Stand?
Published 2013-01-01“…Finally, the recent literature regarding interventions for the prophylaxis and treatment of vasospasm, including hyperdynamic therapy, albumin, calcium channel agonists, statins, magnesium sulfate, and endothelin antagonists is summarized. …”
Get full text
Article -
177
Treatment of Nonalcoholic Steatohepatitis in Adults: Present and Future
Published 2015-01-01“…Other drugs have been studied such as metformin, ursodeoxycholic acid, statins, pentoxiphylline, and orlistat with only partially positive results. …”
Get full text
Article -
178
The Story of CD4+CD28− T Cells Revisited: Solved or Still Ongoing?
Published 2015-01-01“…So far it has been shown that treatment with TNF-α blockers, abatacept, statins, and polyclonal antilymphocyte globulins (ATG) mediates reduction of the CD4+CD28− T cell level. …”
Get full text
Article -
179
Atorvastatin-Diltiazem Combination Induced Rhabdomyolysis Leading to Diagnosis of Hypothyroidism
Published 2017-01-01“…Statins and hypothyroidism, independently, can rarely cause rhabdomyolysis. …”
Get full text
Article -
180
Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function
Published 2016-01-01“…Treatment should be directed to improve etiologic factors besides reducing symptoms; several approaches have been evaluated to reduce neuropathic impairments and improve nerve conduction, such as oral antidiabetics, statins, and antioxidants (alpha-lipoic acid, ubiquinone, and flavonoids).…”
Get full text
Article